2009

United BioSource Acquires Cognitive Testing Company CDR

Monday, September 21, 2009

Bethesda, Md.-based contract research organization (CRO) United BioSource Corporation (UBC) acquired computerized cognitive testing services company Cognitive Drug Research (CDR) for an undisclosed sum.  With the addition of CDR’s cognitive testing services, UBC plans to create an integrated solution to reliably assess cognitive function—a service that UBC said is needed in the clinical trial industry.

[Read More]

ICON, QPS Receive Industry Accreditations

Friday, September 18, 2009

Dublin, Ireland-based contract research organization (CRO) ICON received industry accreditations for three of its laboratories in the UK and Singapore, and Newark, Del.-based QPS received a Good Laboratory Practice (GLP) certificate for its Taiwan operations.

[Read More]

MDS Pharma Revenues Continue to Fall, Hunt for Buyer Continues

Friday, September 11, 2009

Revenues continue to fall at MDS Pharma, the contract research arm of Toronto-based MDS. Third-quarter 2009 net revenues fell 28% from the same period last year, dropping to $49 million from $68 million. The year-over-year decline was a result of decreased demand for phase I and bioanalytical services, the company said.

[Read More]